News
A patient with relapsed follicular lymphoma achieved complete remission one month after PMB-CT01 treatment in the phase 1 PMB ...
Enterome to present positive Phase 2 indolent non-Hodgkin lymphoma data for its OncoMimics™ EO2463 at ICMLPresentation at the International Conference on Malignant Lymphoma (ICML) in Lugano on June ...
STARLIGHT-1 trial has dosed the first patient in the second cohort of the study evaluating EB103 in advanced B-cell ...
The findings suggest assessment of CD20 may be an important factor in determining treatment options in B-cell lymphomas.
Iksuda Therapeutics (Iksuda), the developer of class-leading antibody drug conjugates (ADCs) with clinically validated tumour-selective payload release formats, today announces the completion of ...
The Nordic Protocol is a type of chemoimmunotherapy treatment. It combines chemotherapy (which slows the growth of cancer ...
28d
Justdial on MSNAnaplastic Large-Cell Lymphoma: Causes, Symptoms, Diagnosis and TreatmentLearn about Anaplastic Large-Cell Lymphoma (ALCL), including its causes, symptoms, diagnosis and treatment options for better ...
Estrella Immunopharma, Inc. (NASDAQ: ESLA) ("Estrella" or the "Company"), a clinical stage biopharmaceutical company ...
Australian comedy icon Magda Szubanski has been diagnosed with a rare blood cancer. Here's what we know about it.
Hosted on MSN24d
7MM B-cell non-Hodgkin’s lymphoma cases to reach 230,000 in 2033Diagnosed incident cases of B-cell non-Hodgkin’s lymphoma (B-cell NHL) across the seven major markets (7MM) are expected to increase from 200,844 in 2023 to nearly 230,000 by 2033 at an annual ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results